Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma

Keyphrases

• Prognostic Factors 100%
• Pretransplant 100%
• Clinical Outcomes 100%
• Autologous Stem Cell Transplantation (auto-SCT) 100%
• Clinical Prognostic 100%
• Extranodal Natural killer/T-cell Lymphoma 100%
• Advanced Disease 75%
• Limited Disease 75%
• Primary Therapy 50%
• Complete Remission 50%
• Progression-free Survival 50%
• Radiotherapy 25%
• Newly Diagnosed 25%
• Multivariate Analysis 25%
• Early Progression 25%
• Advanced Stage 25%
• Partial Remission 25%
• Intermediate Risk 25%
• Overall Survival 25%
• International Prognostic Index 25%
• Prognostic Score 25%
• Poor Risk 25%
• Lymphoma Patients 25%
• Active Treatment 25%
• Risk Characteristics 25%
• 3-year Survival 25%
• Independent Prognostic Factor 25%
• Anthracycline-based Chemotherapy 25%
• Poor Prognostic Factors 25%
• NK/T-cell Lymphoma 25%

Medicine and Dentistry

• Prognostic Factor 100%
• Autologous Stem Cell Transplantation 100%
• NK T Cell Lymphoma 100%
• Diseases 100%
• Overall Survival 33%
• Progression Free Survival 33%
• International Prognostic Index 16%
• Anthracycline 16%
• Radiation Therapy 16%
• Chemotherapy 16%
• Multivariate Analysis 16%
• Independent Factor 16%
• Active Treatment 16%
• Median Follow Up 16%

Immunology and Microbiology

• Natural Killer T Cell 100%
• Autologous Stem Cell Transplantation 100%
• Overall Survival 40%
• Progression Free Survival 40%